|
1
|
Leich E, Weißbach S, Klein HU, Grieb T,
Pischimarov J, Stühmer T, Chatterjee M, Steinbrunn T, Langer C,
Eilers M, et al: Multiple myeloma is affected by multiple and
heterogeneous somatic mutations in adhesion- and receptor tyrosine
kinase signaling molecules. Blood Cancer J. 3:e1022013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schmidt-Hieber M, Gutiérrez ML,
Pérez-Andrés M, Paiva B, Rasillo A, Tabernero MD, Sayagués JM,
Lopez A, Bárcena P, Sanchez ML, et al: Cytogenetic profiles in
multiple myeloma and monoclonal gammopathy of undetermined
significance: A study in highly purified aberrant plasma cells.
Haematologica. 98:279–287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keats JJ, Maxwell CA, Taylor BJ, Hendzel
MJ, Chesi M, Bergsagel PL, Larratt LM, Mant MJ, Reiman T, Belch AR
and Pilarski LM: Overexpression of transcripts originating from the
MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple
myeloma patients. Blood. 105:4060–4069. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Toman I, Loree J, Klimowicz AC, Bahlis N,
Lai R, Belch A, Pilarski L and Reiman T: Expression and prognostic
significance of Oct2 and Bob1 in multiple myeloma: Implications for
targeted therapeutics. Leuk Lymphoma. 52:659–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szudyszczyrek A, Szczyrek M,
Sorokawojtaszko M and Hus M: New prognostic biomarkers in multiple
myeloma. Postepy Hig Med Dosw (Online). 70:811–819. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pfisterer P, König H, Hess J, Lipowsky G,
Haendler B, Schleuning WD and Wirth T: CRISP-3, a protein with
homology to plant defense proteins, is expressed in mouse B cells
under the control of Oct2. Mol Cell Biol. 16:6160–6168. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wirth T, Pfisterer P, Annweiler A,
Zwilling S and König H: Molecular principals of Oct2-mediated gene
activation in B cells. Immunobiology. 193:161–170. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Udby L, Cowland JB, Johnsen AH, Sørensen
OE, Borregaard N and Kjeldsen L: An ELISA for SGP28/CRISP-3, a
cysteine-rich secretory protein in human neutrophils, plasma, and
exocrine secretions. J Immunol Methods. 263:43–55. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raje N, Woo SB, Hande K, Yap JT,
Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri
S, et al: Clinical, radiographic, and biochemical characterization
of multiple myeloma patients with osteonecrosis of the jaw. Clin
Cancer Res. 14:2387–2395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garg TK, Szmania SM, Khan JA, Hoering A,
Malbrough PA, Moreno-Bost A, Greenway AD, Lingo JD, Li X, Yaccoby
S, et al: Highly activated and expanded natural killer cells for
multiple myeloma immunotherapy. Haematologica. 97:1348–1356. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kiaii S, Clear AJ, Ramsay AG, Davies D,
Sangaralingam A, Lee A, Calaminici M, Neuberg DS and Gribben JG:
Follicular lymphoma cells induce changes in T-cell gene expression
and function: Potential impact on survival and risk of
transformation. J Clin Oncol. 31:2654–2661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rhodes DR, Barrette TR, Rubin MA, Ghosh D
and Chinnaiyan AM: Meta-analysis of microarrays: Interstudy
validation of gene expression profiles reveals pathway
dysregulation in prostate cancer. Cancer Res. 62:4427–4433.
2002.PubMed/NCBI
|
|
13
|
Barrett T and Edgar R: Gene expression
omnibus: Microarray data storage, submission, retrieval, and
analysis. Methods Enzymol. 411:352–369. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rudy J and Valafar F: Empirical comparison
of cross-platform normalization methods for gene expression data.
BMC Bioinformatics. 12:4672011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shabalin AA, Tjelmeland H, Fan C, Perou CM
and Nobel AB: Merging two gene-expression studies via
cross-platform normalization. Bioinformatics. 24:1154–1160. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shain KH and Dalton WS: Genetic and
environmental determinants in multiple myeloma: Implications for
therapy. Springer Netherlands. 14:53–82. 2012.
|
|
17
|
Mattioli M, Agnelli L, Fabris S, Baldini
L, Morabito F, Bicciato S, Verdelli D, Intini D, Nobili L, Cro L,
et al: Gene expression profiling of plasma cell dyscrasias reveals
molecular patterns associated with distinct IGH translocations in
multiple myeloma. Oncogene. 24:2461–2473. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:pp. 5116–5121. 2001;
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saligan LN, Hsiao CP, Wang D, Wang XM, St
John L, Kaushal A, Citrin D, Barb JJ, Munson PJ and Dionne RA:
Upregulation of alpha-synuclein during localized radiation therapy
signals the association of cancer-related fatigue with the
activation of inflammatory and neuroprotective pathways. Brain
Behav Immun. 27:63–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Canales NA, Marina VM, Castro JS, Jiménez
AA, Mendoza-Hernández G, McCARRON EL, Roman MB and Castro-Romero
JI: A1BG and C3 are overexpressed in patients with cervical
intraepithelial neoplasia III. Oncol Lett. 8:939–947. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Misiewicz-Krzeminska I, Sarasquete ME,
Vicente-Dueñas C, Krzeminski P, Wiktorska K, Quwaider D, Rojas EA,
Corral R, Corchete LA, Martin AA, et al: Post-Transcriptional
modifications explain the overexpression of CCND2 in multiple
myeloma. Blood. 124:20012014.PubMed/NCBI
|
|
25
|
Scheidereit C, Heguy A and Roeder RG:
Identification and purification of a human lymphoid-specific
octamer-binding protein (OTF-2) that activates transcription of an
immunoglobulin promoter in vitro. Cell. 51:783–793. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Staudt LM, Singh H, Sen R, Wirth T, Sharp
PA and Baltimore D: A lymphoid-specific protein binding to the
octamer motif of immunoglobulin genes. Nature. 323:640–643. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al Bashir S, Alshalalfa M, Hegazy SA,
Dolph M, Donnelly B and Bismar TA: Cysteine-rich secretory protein
3 (CRISP3), ERG and PTEN define a molecular subtype of prostate
cancer with implication to patients' prognosis. J Hematol Oncol.
7:212014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ribeiro FR, Paulo P, Costa VL,
Barros-Silva JD, Ramalho-Carvalho J, Jerónimo C, Henrique R, Lind
GE, Skotheim RI, Lothe RA and Teixeira MR: Cysteine-rich secretory
protein-3 (CRISP3) is strongly Up-regulated in prostate carcinomas
with the TMPRSS2-ERG fusion gene. PLoS One. 6:e223172011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao Q, Kleeff J, Xiao Y, Guweidhi A,
Schambony A, Töpfer-Petersen E, Zimmermann A, Büchler MW and Friess
H: Preferential expression of cystein-rich secretory protein-3
(CRISP-3) in chronic pancreatitis. Histol Histopathol. 18:425–433.
2003.PubMed/NCBI
|
|
30
|
Ko WC, Sugahara K, Sakuma T, Yen CY, Liu
SY, Liaw GA and Shibahara T: Copy number changes of CRISP3 in oral
squamous cell carcinoma. Oncol Lett. 3:75–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
López-Corral L, Corchete LA, Sarasquete
ME, Mateos MV, García-Sanz R, Fermiñán E, Lahuerta JJ, Bladé J,
Oriol A, Teruel AI, et al: Transcriptome analysis reveals molecular
profiles associated with evolving steps of monoclonal gammopathies.
Haematologica. 99:1365–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
André T, Meuleman N, Stamatopoulos B, De
Bruyn C, Pieters K, Bron D and Lagneaux L: Evidences of early
senescence in multiple myeloma bone marrow mesenchymal stromal
cells. PLoS One. 8:e597562013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grupp K, Kohl S, Sirma H, Simon R, Steurer
S, Becker A, Adam M, Izbicki J, Sauter G, Minner S, et al:
Cysteine-rich secretory protein 3 overexpression is linked to a
subset of PTEN-deleted ERG fusion-positive prostate cancers with
early biochemical recurrence. Mod Pathol. 26:733–742. 2013.
View Article : Google Scholar : PubMed/NCBI
|
